The Indian pharmaceutical industry has emerged as a global player in the past few decades, becoming one of the largest producers of generic drugs worldwide. The business of Indian pharmaceuticals has witnessed exponential growth, expanding its presence in both domestic and international markets.

The Indian pharmaceutical sector holds tremendous potential due to its vast pool of skilled professionals, cost-effective manufacturing capabilities, and large-scale production capacities. The country’s strong research and development infrastructure further contribute to its success in the pharma business. India is home to several renowned pharmaceutical research institutions and has a robust regulatory framework to ensure quality standards are met.

The Indian pharmaceutical industry has achieved significant milestones in recent years. It has successfully developed and manufactured a wide range of generic drugs, thereby making healthcare more affordable and accessible globally. The affordability of Indian drugs has played a crucial role in providing healthcare solutions to developing nations, as well as contributing to the reduction of healthcare costs in developed countries.

India’s expertise in producing high-quality generic drugs has also enabled it to become a major supplier of pharmaceutical products to countries around the world. Indian pharmaceutical firms have expanded their operations by establishing manufacturing facilities and research centers in various countries, allowing them to cater to the specific needs of different markets.

The pharma business in India has not only focused on generics but also made strides in pharmaceutical research and development. Several Indian companies have made significant investments in innovative drug discovery, with a strong focus on biotechnology and biosimilars. This has led to the development of breakthrough drugs for various diseases, enhancing India’s reputation as a center for pharmaceutical innovation.

Overview

Multinational pharmaceutical company headquartered in India. It is one of the leading generic pharmaceutical companies in Asia, it operates in more than 30 countries and has a diverse portfolio of products ranging from prescription drugs to over-the-counter medications and active pharmaceutical ingredients.

The company is known for its strong research and development capabilities and has a reputation for manufacturing high-quality and affordable medicines. The company is committed to improving access to healthcare globally and strives to make a positive impact on people’s lives through its innovative products and sustainable practices.

Currently the company do mostly Private Label, do not commercialize its own brand, but manufacture most of the common Pharmaceutical forms (Syrups, Capsules, Tablets, Powders, Lotions, solutions).

Keypoints

1. Focused on manufacturing and marketing generic drugs, active pharmaceutical ingredients (APIs), and custom pharmaceutical services.
2. The company has a diverse portfolio of products spanning various therapeutic categories, including cardiovascular, neurology, gastrointestinal, dermatology, and oncology.
3. Global presence and operates in more than 30 countries worldwide.
4. Strong focus on research and development, investing a significant portion of its revenues in R&D activities.
5. Dedicated team of scientists and researchers who work on developing new drug formulations and improving existing ones.
6. Robust pipeline of new products, with several filings and approvals in various countries.
7. Known for its emphasis on quality and compliance with international regulatory standards.
8. Several manufacturing facilities in India and abroad, which adhere to good manufacturing practices (GMP) guidelines.
9. Strong track record of successfully launching and marketing generic versions of blockbuster drugs globally.
10. Established partnerships and collaborations with leading pharmaceutical companies to access new molecules and markets.

KYC, POF REQUIRED